Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
---|
12/27/2007 | US20070299023 P185Neu-Encoding Dna and Therapeutical Uses Thereof |
12/27/2007 | US20070299021 Modified Tailed Oligonucleotides |
12/27/2007 | US20070299011 Appoptosin and uses thereof for treating neurodegenerative disease and cancer |
12/27/2007 | US20070298493 Transgenic animal cells containing endotheilial growth factor polypeptide for use as model system for treatment of cardiovascular and respiratory system disorders |
12/27/2007 | US20070298066 Biodegradable linkers for molecular therapies |
12/27/2007 | US20070298055 Vaccine composition comprising non-human, mammalian 5T4 antigen for prevention of cell proliferative disorders |
12/27/2007 | US20070298051 Adjuvants Of Immune Response |
12/27/2007 | US20070298048 Non-viral gene delivery system |
12/27/2007 | US20070298026 Methods for Identifying Treatment and Inducing Infertility Using Smc1-Beta |
12/27/2007 | US20070298021 Methods and Compositions for the Treatment or Prevention of Secondary Ischemic Injury |
12/27/2007 | US20070298012 Compositions and Methods for Tumor-Targeted Delivery of Effector Molecules |
12/27/2007 | US20070298006 Dendritic Polymers With Enhanced Amplification and Interior Functionality |
12/27/2007 | US20070297991 Neural conduit agent dissemination for smoking cessation and other applications |
12/27/2007 | US20070297986 Screening methods for identifying agents useful for treating or reducing visual impairment in mammals |
12/27/2007 | CA2656259A1 Process for producing poxviruses and poxvirus compositions |
12/27/2007 | CA2655990A1 Restoration of hearing loss |
12/27/2007 | CA2655933A1 Polynucleotides and polypeptide sequences involved in cancer |
12/27/2007 | CA2655763A1 Viral capsid proteins and any peptides or compositions thereof for the treatment of pathologic disorders |
12/27/2007 | CA2652858A1 Methods for treating target joints in inflammatory arthritis using aav vectors encoding a tnf antagonist |
12/26/2007 | EP1870473A1 Adeno-associated virus-mediated delivery of angiogenic factors |
12/26/2007 | EP1870467A1 Polypeptide hormone Phosphatonin |
12/26/2007 | EP1870461A2 Method for identifying within a mammal a DNA encoding physiologically active polypeptide |
12/26/2007 | EP1870110A1 Preparation comprising microparticles of complex composed of nucleic acid molecule and collagen |
12/26/2007 | EP1869470A1 Use of protein 2e9 for in vitro diagnosis of mycoplasma pneumoniae infections |
12/26/2007 | EP1869181A2 Influenza therapeutic |
12/26/2007 | EP1869170A2 Isolated myeloid-like bone marrow cell populations and methods of treatment therewith |
12/26/2007 | EP1868654A2 Seneca valley virus based compositions and methods for treating disease |
12/26/2007 | EP1265914B1 Wnt-1 related polypeptides, and nucleic acids encoding the same |
12/26/2007 | EP1235596B1 Use of lytic toxins and toxin conjugates |
12/26/2007 | EP1187634B1 Cell growth inhibition |
12/26/2007 | EP1045703A4 Stabilization of lipid:dna formulations during nebulization |
12/26/2007 | EP0973895B1 Transcription factor islet-brain 1 (ib1) |
12/26/2007 | CN101094691A 载体 Carrier |
12/26/2007 | CN101092636A Selectively replicating viral vectors |
12/26/2007 | CN101092635A pUCpGs plasmid with immunity activation, preparation method and application |
12/26/2007 | CN101092631A Modified ORF2 gene of toroidal virus of pig, and application |
12/26/2007 | CN101092630A Synthesizing virus genome of West Nile fever, and kit for detecting virus |
12/26/2007 | CN101092621A Uncoupling protein gene of lamprey and application |
12/26/2007 | CN101092620A Structure and application of antisense oligonucleotide of anti influenza virus with target directional apoptosis induction factor |
12/26/2007 | CN101091798A Application of meaning inversed miRNA-210 |
12/26/2007 | CN101091797A Method for taking off endotoxin in primary pure plasmids or proteins, and kit |
12/26/2007 | CN101091795A Prevention and treatment of synucleinopathic disease |
12/26/2007 | CN100357443C Paramyxovirus vector encoding angiogenesis gene and utilization thereof |
12/26/2007 | CN100357433C eNOS mutations useful for gene therapy and therapeutic screening |
12/26/2007 | CN100356982C Adeno-associated virus vector preparation and medicinal composition containing it and its use |
12/26/2007 | CN100356981C Ligand oligopeptide specific combining human epidermal growth factor receptor EGFR |
12/25/2007 | US7312373 Nonhuman model animal lacking the ability to control lymphocyte migration |
12/25/2007 | US7312324 Recombinant transgene useful for expression of a coding sequence, comprising a strong constitutive promoter and one or more liver-specific enhancer elements. |
12/25/2007 | US7312321 Antibody to human enzymes of the metalloprotease family |
12/25/2007 | US7312206 Sterol derivatives, liposomes comprising sterol derivatives and method for loading liposomes with active substances |
12/25/2007 | US7312078 Methods of controlling proliferation and differentiation of stem and progenitor cells |
12/25/2007 | US7312077 Insulin-secreting immortalized liver cell line modified by glucose sensitivity |
12/25/2007 | US7312051 Polynucleotides encoding dendritic enriched secreted lymphocyte activation molecule |
12/25/2007 | US7312050 Nucleic acids encoding interphotoreceptor matrix proteins |
12/25/2007 | US7311922 comprising antigens and excipients, which increse serological sensitivity of individuals infected with tuberculosis; for use in diagnosis and prevention of tuberculosis infection |
12/25/2007 | US7311921 Effective against FIVDix, FIVUK8, FIVBang, FIVAom1, FIVAom2, FIVPet, and FIVShi. |
12/25/2007 | US7311917 Membrane proteins; fusion proteins; vaccines; kits |
12/25/2007 | US7311907 Lentiviral packaging cells |
12/21/2007 | WO2007147168A2 Attenuation of hyperoxia-induced cell death with mitochondrial aldehyde dehydrogenase |
12/21/2007 | WO2007147067A2 Methods and compositions for regulating cell cycle progression |
12/21/2007 | WO2007147011A2 Polynucleotide therapy |
12/21/2007 | WO2007147007A2 Methods and immune modulatory nucleic acid compositions for preventing and treating disease |
12/21/2007 | WO2007146309A2 Methods for manipulating stem cells |
12/21/2007 | WO2007146190A2 Sex- specific regulation of aging and apoptosis |
12/21/2007 | WO2007146046A2 Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders |
12/21/2007 | WO2007145365A1 Therapeutic agent for cancer and method for screening for the same |
12/21/2007 | WO2007145306A1 Element having long blood-circulating time which is degradable selectively in tumor tissue |
12/21/2007 | WO2007144985A1 Use of rpn2 gene expression inhibitor |
12/21/2007 | WO2007143858A1 Dph2 gene deletion mutant and uses thereof |
12/21/2007 | WO2007116276A3 Integrin binding rgd-lipopeptides with gene transfer activities |
12/21/2007 | WO2007115047A3 Inhibition of hiv replication and expression of p24 with eif-5a |
12/21/2007 | WO2007096187A3 Computer gene |
12/21/2007 | WO2007089871A8 Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders |
12/21/2007 | WO2004071405A3 Lactate dehydrogenase: a target and reagent for diabetes therapy |
12/21/2007 | CA2655565A1 Dph2 gene deletion mutant and uses thereof |
12/21/2007 | CA2655355A1 Use of rpn2 gene expression inhibitor |
12/20/2007 | US20070294780 Facilitation of oocyte, zygote and pre-implantation embryo maturation |
12/20/2007 | US20070293663 modified oligonucleotide consisting of 12 to 30 linked nucleosides for modulating the expression of signal transducer and activator of transcription (STAT) proteins |
12/20/2007 | US20070293453 Combinatorial Methods For Inducing Cancer Cell Death |
12/20/2007 | US20070293450 Identification of ses-3 and the uses of same |
12/20/2007 | US20070293449 Compositions and methods for delivery of double-stranded rna |
12/20/2007 | US20070293448 Synthetic gagpol genes and their uses |
12/20/2007 | US20070293447 Gene Therapy for Skin Disorders Using Needleless Syringes |
12/20/2007 | US20070292904 Ephrin and EPH receptor mediated immune modulation |
12/20/2007 | US20070292885 Human cdnas and proteins and uses thereof |
12/20/2007 | US20070292427 Substantially pure steroidogenesis inducing peptide and uses thereof |
12/20/2007 | US20070292412 Novel genes and markers in type 2 diabetes and obesity |
12/20/2007 | US20070292408 compositions capable of blocking the inhibitory effect of a newly-identified intronic inhibitory sequence element, named ISS-N1 (intronic splicing silencer), located in the SMN2 gene |
12/20/2007 | US20070292401 Soft tissue repair and regeneration using stem cell products |
12/20/2007 | US20070292394 Treatment of non-neuronal cancer using hsv-1 variants |
12/20/2007 | US20070292386 Vaccine formulations for intradermal delivery comprising adjuvants and antigenic agents |
12/20/2007 | US20070292350 Method For Testing A Compound For A Therapeutic Effect And A Diagnostic Method |
12/20/2007 | US20070292348 Treating Wnt signaling-related diseases, for detecting mammary basal-like cells, for diagnosing basal-like breast cancer, and for inhibiting proliferation of a tumor expressing LRP6 |
12/19/2007 | EP1867721A1 Angiostatin fragments and aggregate angiostatin and methods of use |
12/19/2007 | EP1867720A2 Purified genes encoding mammalian cell surface antigens; proteins and antibodies |
12/19/2007 | EP1867718A2 Therapeutically useful synthetic oligonucleotides |
12/19/2007 | EP1867717A1 Method of ameliorating symptom caused by mood disturbance |
12/19/2007 | EP1867715A1 Light activated gene transduction using ultraviolet light for cell targeted gene delivery |
12/19/2007 | EP1866422A2 Method of increasing the function of an aav vector |
12/19/2007 | EP1865992A2 Treatment for heart disease |